Hepatic manifestations of inflammatory bowel diseases.

about

Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice.Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

P2860

Q49959033-8A7E548F-8CAB-4C05-831D-C0915D4593A5 Q55114620-328A7CB3-427A-4053-9AF7-329C8AED1E46

P2860

Hepatic manifestations of inflammatory bowel diseases.

Item

http://www.wikidata.org/entity/Q38814158

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Hepatic manifestations of inflammatory bowel diseases.

@en

type

Item

label

Hepatic manifestations of inflammatory bowel diseases.

@en

prefLabel

Hepatic manifestations of inflammatory bowel diseases.

@en

P1476

Hepatic manifestations of inflammatory bowel diseases.

@en

P2093

Jean-Louis Frossard

http://www.w3.org/2001/XMLSchema#string

Olivier Chazouillères

http://www.w3.org/2001/XMLSchema#string

Sophie Restellini

http://www.w3.org/2001/XMLSchema#string

P2860

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer

Hepatic manifestations of non-steroidal inflammatory bowel disease therapy

Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk

Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases

Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article

Sulfasalazine-induced fulminant hepatic failure

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

P304

475-489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.13265

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27712010

http://www.w3.org/2001/XMLSchema#string

Hepatic manifestations of inflammatory bowel diseases.

about

P2860

P2860

Hepatic manifestations of inflammatory bowel diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698